BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Current Deferred Revenue (2020 - 2024)

BeyondSpring's (BYSI) quarterly Current Deferred Revenue came in at $2.0 million in Q2 2024, up 14.28% year-over-year from $1.8 million in Q3 2023, and up 14.28% quarter-over-quarter from $1.8 million in Q4 2023.

Analysis

BeyondSpring (BYSI) Current Deferred Revenue (2020 - 2024) Analysis & Trends

BeyondSpring has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $2.0 million for Q2 2024.

  • In Q2 2024, Current Deferred Revenue rose 14.28% year-over-year to $2.0 million; the TTM figure through Jun 2024 stood at $2.0 million (up 14.28% YoY), while the FY2023 annual figure was $1.8 million, up 29.61% from the prior year.
  • Current Deferred Revenue came in at $2.0 million for Q2 2024 at BeyondSpring, up from $1.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.0 million in Q2 2024 to a low of $1.3 million in Q4 2020.
  • Average Current Deferred Revenue over 5 years is $1.5 million, with a median of $1.4 million recorded in 2021.
  • Year-over-year, Current Deferred Revenue slipped 1.31% in 2022 and advanced 29.61% in 2023.
  • Over 5 years, Current Deferred Revenue stood at $1.3 million in 2020, then increased by 1.41% to $1.4 million in 2021, then retreated by 1.31% to $1.4 million in 2022, then grew by 29.61% to $1.8 million in 2023, then increased by 14.28% to $2.0 million in 2024.
  • Per Business Quant data, the three most recent Current Deferred Revenue figures were $2.0 million in Q2 2024, $1.8 million in Q4 2023, and $1.8 million in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn
10 BeyondSpring 31.51 Mn 31.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 2.00 Mn
Dec 31, 2023 1.75 Mn
Jun 30, 2023 1.75 Mn
Dec 31, 2022 1.35 Mn
Jun 30, 2022 1.35 Mn
Dec 31, 2021 1.37 Mn
Sep 30, 2021 1.53 Mn
Jun 30, 2021 1.35 Mn
Mar 31, 2021 1.35 Mn
Dec 31, 2020 1.35 Mn